
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Study Phase : Discovery Platform
Sponsor : Zuse Institute Berlin
Deal Size : Undisclosed
Deal Type : Collaboration
Qanatpharma, Zuse Institute Berlin, Enamine and Proteros Announce Collaboration
Details : An international discovery collaboration is harnessing AI-powered drug discovery to develop a first-in-class therapy to prevent delayed cerebral ischemia in patients with subarachnoid hemorrhage.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
July 09, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Highest Development Status : Discovery Platform
Sponsor : Zuse Institute Berlin
Deal Size : Undisclosed
Deal Type : Collaboration
